Strand and ChemAxon enter into Collaboration
Strand Life Sciences, announced today that it has integrated ChemAxon’s JChem suite of software with admetis, its tool for modeling and predicting drug-relevant properties of molecules in silico. The integrated offering will be launched in the early part of Q1 2006.
admetis is a comprehensive tool for modeling and predicting drug-relevant properties of molecules in silico. It gives users the power to build custom models using their own data. This is made possible through easy and intuitive model-building workflows based on Strand’s expertise in in silico model building. admetis comes packaged with its pre-built models, truPK and truTox, for predicting Bioavailability, Protein binding, Volume distribution, Elimination half life, Rate of absorption and hERG binding. admetis has an extensive data mining and visualization module that supports an embedded chemical structure viewer.
The inclusion of ChemAxon’s JChem toolkit provides admetis with a feature rich, chemically aware data management and search framework. admetis users will be able to enjoy state-of-the-art chemical editing and visualization capabilities as well as the power to build complex queries using structural and non-structural data.
“admetis couples pre-built models with a workflow-based modeling platform making it a distinct offering,” said Kas Subramanian, CSO, Strand Life Sciences. “Some of the key features of JChem directly address the requests from our prospects and customers. We believe that this integration will benefit our customers,” he added.
“We are happy that we have such a good fit with the admetis offering and given Strands expertise and ambitious plans for future development we see a bright future for the collaboration,” said Ferenc Csizmadia, CEO of ChemAxon.
About Strand Life Sciences Pvt Ltd
Strand Life Sciences is a premier in silico technologies innovation company focused on developing technologies for drug discovery and development. Strand has three streams of business spanning early target discovery through pre-clinical development. The first is centred on informatics tools and solutions for the research biologist with a focus on visualization and analytics for array technologies and including oligo design, image analysis and information management systems. A second stream of products include a cheminformatics modeling platform admetis and proprietary in silico predictive models for small molecule drug properties like ADME and Cardiotoxicity with models for Hepatotoxicity in the pipeline. Strand also partners with discovery contract research companies to combine in silico and wet labs to offer services starting from compound library design to lead generation. Please visit www.strandls.com for more information.
About ChemAxon
ChemAxon is a leader in providing Java-based chemical software development platforms for the biotechnology and pharmaceutical industries. With core capabilities for structure visualization and management, property prediction, virtual synthesis, screening and drug design, ChemAxon focuses upon active interaction with users and portability to create powerful, cost effective cross platform solutions and programming interfaces to power modern cheminformatics and chemical communication. For more information please visit www.chemaxon.com .
